{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T08:33:31Z","timestamp":1793694811208,"version":"4.5.1"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100023581","name":"National Science Foundation Graduate Research Fellowship Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100023581","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2023M742101"],"award-info":[{"award-number":["2023M742101"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People&apos;s Republic of China","doi-asserted-by":"publisher","award":["2023YFC2606500"],"award-info":[{"award-number":["2023YFC2606500"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Shandong Province Natural Science Foundation","doi-asserted-by":"publisher","award":["ZR2024QH201"],"award-info":[{"award-number":["ZR2024QH201"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic &amp; Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.bmcl.2025.130110","type":"journal-article","created":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T07:18:06Z","timestamp":1737962286000},"page":"130110","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Nucleoside antiviral agents with atypical structures and new targets"],"prefix":"10.1016","volume":"119","author":[{"given":"Hui","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baohu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinfei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7168-613X","authenticated-orcid":false,"given":"Peng","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2025.130110_b0005","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/s41573-023-00672-y","article-title":"Therapeutic strategies for COVID-19: progress and lessons learned","volume":"22","author":"Li","year":"2023","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.bmcl.2025.130110_b0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114554","article-title":"HIV nucleoside reverse transcriptase inhibitors","volume":"240","author":"Amblard","year":"2022","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2025.130110_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115292","article-title":"Potential RNA-dependent RNA polymerase (RdRp) inhibitors as prospective drug candidates for SARS-CoV-2","volume":"252","author":"Bekheit","year":"2023","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2025.130110_b0020","article-title":"Recent advancements in the delivery of therapeutic agents targeting RNA-dependent RNA polymerase of SARS-CoV-2","author":"Mahajan","year":"2024","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.bmcl.2025.130110_b0025","doi-asserted-by":"crossref","DOI":"10.3390\/ph17050661","article-title":"Small molecule drugs targeting viral polymerases","volume":"17","author":"Palazzotti","year":"2024","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.bmcl.2025.130110_b0030","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1093\/jac\/dkl123","article-title":"Antiviral options for the treatment of chronic hepatitis B","volume":"57","author":"Osborn","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.bmcl.2025.130110_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115196","article-title":"Recent advances on dual inhibitors targeting HIV reverse transcriptase associated polymerase and ribonuclease H","volume":"250","author":"Kang","year":"2023","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2025.130110_b0040","article-title":"Insights into novel inhibitors intending HCMV protease a computational molecular modelling investigation for antiviral drug repurposing","volume":"48","author":"Siddiquee","year":"2024","journal-title":"Inf Med Unlocked"},{"key":"10.1016\/j.bmcl.2025.130110_b0045","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-15930-z","article-title":"Hepatitis C virus NS3\/4A inhibitors and other drug-like compounds as covalent binders of SARS-CoV-2 main protease","volume":"12","author":"Andi","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.bmcl.2025.130110_b0050","doi-asserted-by":"crossref","DOI":"10.1007\/s00284-024-03671-3","article-title":"An overview of SARS-CoV-2 potential targets, inhibitors, and computational insights to enrich the promising treatment strategies","volume":"81","author":"Kumawat","year":"2024","journal-title":"Curr Microbiol"},{"key":"10.1016\/j.bmcl.2025.130110_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2023.136272","article-title":"Recent advancements in NS5B inhibitors (2011-2021): structural insights, SAR studies and clinical status","volume":"1293","author":"Kumar","year":"2023","journal-title":"J Mol Struct"},{"key":"10.1016\/j.bmcl.2025.130110_b0060","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/bs.enz.2021.09.003","article-title":"Herpesvirus DNA polymerase: structures, functions, and mechanisms","volume":"50","author":"Coen","year":"2021","journal-title":"Enzymes"},{"key":"10.1016\/j.bmcl.2025.130110_b0065","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1021\/acs.jmedchem.6b01227","article-title":"Inhibitors of influenza virus polymerase acidic (PA) endonuclease: contemporary developments and perspectives","volume":"60","author":"Ju","year":"2017","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2025.130110_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2023.105791","article-title":"Current state and challenges in respiratory syncytial virus drug discovery and development","volume":"221","author":"Zou","year":"2024","journal-title":"Antiviral Res"},{"key":"10.1016\/j.bmcl.2025.130110_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113698","article-title":"Insights on dengue and Zika NS5 RNA-dependent RNA polymerase (RdRp) inhibitors","volume":"224","author":"Nascimento","year":"2021","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2025.130110_b0080","doi-asserted-by":"crossref","unstructured":"Choi KH. Viral polymerases. In: Rossmann MG, Rao VB, editors. Viral molecular machines; 2012. p. 267\u2013304.","DOI":"10.1007\/978-1-4614-0980-9_12"},{"key":"10.1016\/j.bmcl.2025.130110_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2021.131756","article-title":"RdRp (RNA-dependent RNA polymerase): a key target providing anti-virals for the management of various viral diseases","volume":"1250","author":"Pathania","year":"2022","journal-title":"J Mol Struct"},{"key":"10.1016\/j.bmcl.2025.130110_b0090","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.2174\/138161206776361156","article-title":"Antiviral therapy targeting viral polymerase","volume":"12","author":"Tsai","year":"2006","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.bmcl.2025.130110_b0095","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1016\/j.bmcl.2015.05.039","article-title":"Design, synthesis and evaluation of a series of acyclic fleximer nucleoside analogues with anti-coronavirus activity","volume":"25","author":"Peters","year":"2015","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2025.130110_b0100","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/095632020401500102","article-title":"Inhibition of severe acute respiratory syndrome-associated coronavirus (SARSCoV) by calpain inhibitors and beta-D-N4-hydroxycytidine","volume":"15","author":"Barnard","year":"2004","journal-title":"Antivir Chem Chemother"},{"key":"10.1016\/j.bmcl.2025.130110_b0105","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1128\/AAC.47.1.244-254.2003","article-title":"Ribonucleoside analogue that blocks replication of bovine viral diarrhea and hepatitis C viruses in culture","volume":"47","author":"Stuyver","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmcl.2025.130110_b0110","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.antiviral.2005.01.003","article-title":"Inhibitory effect of mizoribine and ribavirin on the replication of severe acute respiratory syndrome (SARS)-associated coronavirus","volume":"66","author":"Saijo","year":"2005","journal-title":"Antiviral Res"},{"key":"10.1016\/j.bmcl.2025.130110_b0115","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.antiviral.2006.03.001","article-title":"Enhancement of the infectivity of SARS-CoV in BALB\/c mice by IMP dehydrogenase inhibitors, including ribavirin","volume":"71","author":"Barnard","year":"2006","journal-title":"Antiviral Res"},{"key":"10.1016\/j.bmcl.2025.130110_b0120","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202201912","article-title":"A series of adenosine analogs as the first efficacious anti-SARS-CoV-2 drugs against the B.1.1.529.4 lineage: a preclinical repurposing research study","volume":"7","author":"Rabie","year":"2022","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.bmcl.2025.130110_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiolchem.2022.107768","article-title":"Dual computational and biological assessment of some promising nucleoside analogs against the COVID-19-Omicron variant","volume":"104","author":"Abdalla","year":"2023","journal-title":"Comput Biol Chem"},{"key":"10.1016\/j.bmcl.2025.130110_b0130","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1021\/acsbiomedchemau.2c00039","article-title":"Forodesine and riboprine exhibit strong anti-SARS-CoV-2 repurposing potential: in silico and In Vitro studies","volume":"2","author":"Rabie","year":"2022","journal-title":"ACS Bio Med Chem Au"},{"key":"10.1016\/j.bmcl.2025.130110_b0135","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.201700166","article-title":"Design, synthesis, and the biological evaluation of a new series of acyclic 1,2,3-triazole nucleosides","volume":"350","author":"G\u0142owacka","year":"2017","journal-title":"Arch Pharm (Weinheim)"},{"key":"10.1016\/j.bmcl.2025.130110_b0140","doi-asserted-by":"crossref","first-page":"4419","DOI":"10.1093\/nar\/gkr015","article-title":"Crystal structure of a DNA containing the planar, phenoxazine-derived bi-functional spectroscopic probe C","volume":"39","author":"Edwards","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.bmcl.2025.130110_b0145","first-page":"679","article-title":"Recent advances in the research of broad-spectrum antiviral agents","volume":"55","author":"Huang","year":"2020","journal-title":"Acta Pharm Sin"},{"key":"10.1016\/j.bmcl.2025.130110_b0150","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.antiviral.2019.01.010","article-title":"Antiviral activity spectrum of phenoxazine nucleoside derivatives","volume":"163","author":"Kozlovskaya","year":"2019","journal-title":"Antiviral Res"},{"key":"10.1016\/j.bmcl.2025.130110_b0155","first-page":"640","article-title":"New progress in anti-norovirus drugs and vaccines","volume":"55","author":"Dong","year":"2020","journal-title":"Acta Pharm Sin"},{"key":"10.1016\/j.bmcl.2025.130110_b0160","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3390\/v11020173","article-title":"Targeting the viral polymerase of diarrhea-causing viruses as a strategy to develop a single broad-spectrum antiviral therapy","volume":"11","author":"Bassetto","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.bmcl.2025.130110_b0165","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3390\/ijms22010171","article-title":"Discovery of potential inhibitors for RNA-dependent RNA polymerase of norovirus: virtual screening, and molecular dynamics","volume":"22","author":"Ebenezer","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bmcl.2025.130110_b0170","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1021\/acsinfecdis.4c00122","article-title":"Discovery of C-linked nucleoside analogues with antiviral activity against SARS-CoV-2","volume":"10","author":"Mesaros","year":"2024","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.bmcl.2025.130110_b0175","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.945","article-title":"Nucleoside analog GS-441524: pharmacokinetics in different species, safety, and potential effectiveness against Covid-19","volume":"10","author":"Rasmussen","year":"2022","journal-title":"Pharmacol Res Perspect"},{"key":"10.1016\/j.bmcl.2025.130110_b0180","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-19055-7","article-title":"A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19","volume":"11","author":"Xie","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.bmcl.2025.130110_b0185","first-page":"657","article-title":"Progress research on antiviral drugs targeting polymerases","volume":"31","author":"Zhang","year":"2021","journal-title":"China J Pharm"},{"key":"10.1016\/j.bmcl.2025.130110_b0190","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.antiviral.2016.01.005","article-title":"Design, synthesis, and in vitro biological evaluation of novel 6-methyl-7-substituted-7-deaza purine nucleoside analogs as anti-influenza A agents","volume":"129","author":"Lin","year":"2016","journal-title":"Antiviral Res"},{"key":"10.1016\/j.bmcl.2025.130110_b0195","doi-asserted-by":"crossref","first-page":"8734","DOI":"10.1021\/acs.jmedchem.5b00804","article-title":"Selenoacyclovir and selenoganciclovir: discovery of a new template for antiviral agents","volume":"58","author":"Sahu","year":"2015","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2025.130110_b0200","first-page":"585","article-title":"Advances in human cytomegalovirus inhibitors","volume":"55","author":"Li","year":"2020","journal-title":"Acta Pharm Sin"},{"key":"10.1016\/j.bmcl.2025.130110_b0205","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.ejmech.2013.02.042","article-title":"Design, synthesis, and biological evaluation of new 2'-deoxy-2'-fluoro-4'-triazole cytidine nucleosides as potent antiviral agents","volume":"63","author":"Wu","year":"2013","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2025.130110_b0210","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1021\/acs.jmedchem.6b01766","article-title":"Synthesis and cytostatic and antiviral profiling of thieno-fused 7-deazapurine ribonucleosides","volume":"60","author":"Tich\u00fd","year":"2017","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2025.130110_b0215","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1021\/acsinfecdis.1c00131","article-title":"The structure-based design of SARS-CoV-2 nsp14 methyltransferase ligands yields nanomolar inhibitors","volume":"7","author":"Otava","year":"2021","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.bmcl.2025.130110_b0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115474","article-title":"Structure-guided optimization of adenosine mimetics as selective and potent inhibitors of coronavirus nsp14 N7-methyltransferases","volume":"256","author":"Hausdorff","year":"2023","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2025.130110_b0225","doi-asserted-by":"crossref","first-page":"27410","DOI":"10.1021\/acsomega.3c02815","article-title":"Rational design of highly potent SARS-CoV-2 nsp14 methyltransferase inhibitors","volume":"8","author":"Stefek","year":"2023","journal-title":"ACS Omega"},{"key":"10.1016\/j.bmcl.2025.130110_b0230","doi-asserted-by":"crossref","DOI":"10.1039\/D4MD00422A","article-title":"Discovery of highly potent SARS-CoV-2 nsp14 methyltransferase inhibitors based on adenosine 5\u2032-carboxamides","author":"Kocek","year":"2024","journal-title":"RSC Med Chem"},{"key":"10.1016\/j.bmcl.2025.130110_b0235","first-page":"694","article-title":"Recent advances in the discovery and development of Ebola virus inhibitors","volume":"55","author":"Ren","year":"2020","journal-title":"Acta Pharm Sin"},{"key":"10.1016\/j.bmcl.2025.130110_b0240","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0166-3542(83)90011-6","article-title":"Broad-spectrum antiviral activity of the carbocyclic analog of 3-deazaadenosine","volume":"3","author":"Declercq","year":"1983","journal-title":"Antiviral Res"},{"key":"10.1016\/j.bmcl.2025.130110_b0245","doi-asserted-by":"crossref","first-page":"S240","DOI":"10.1086\/514316","article-title":"Antiviral drug therapy of filovirus infections: S-adenosylhomocysteine hydrolase inhibitors inhibit Ebola virus in vitro and in a lethal mouse model","volume":"179","author":"Huggins","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1016\/j.bmcl.2025.130110_b0250","first-page":"627","article-title":"Progress on the discovery and development of anti-zika virus agents","volume":"55","author":"Li","year":"2020","journal-title":"Acta Pharm Sin"},{"key":"10.1016\/j.bmcl.2025.130110_b0255","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1007\/s00705-017-3345-x","article-title":"Structural basis of Zika virus methyltransferase inhibition by sinefungin","volume":"162","author":"Hercik","year":"2017","journal-title":"Arch Virol"},{"key":"10.1016\/j.bmcl.2025.130110_b0260","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1021\/acschembio.5b00812","article-title":"SAM\/SAH analogs as versatile tools for SAM-dependent methyltransferases","volume":"11","author":"Zhang","year":"2016","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.bmcl.2025.130110_b0265","doi-asserted-by":"crossref","first-page":"18004","DOI":"10.1021\/ja307060p","article-title":"Sinefungin derivatives as inhibitors and structure probes of protein lysine methyltransferase SETD2","volume":"134","author":"Zheng","year":"2012","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmcl.2025.130110_b0270","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1021\/bi047911w","article-title":"Analysis of the quaternary structure of the putative HCMV portal protein PUL104","volume":"44","author":"Dittmer","year":"2005","journal-title":"Biochemistry"},{"key":"10.1016\/j.bmcl.2025.130110_b0275","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1128\/AAC.46.2.478-486.2002","article-title":"Phosphorylation of beta-D-ribosylbenzimidazoles is not required for activity against human cytomegalovirus","volume":"46","author":"Krosky","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmcl.2025.130110_b0280","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1128\/AAC.48.5.1647-1651.2004","article-title":"Mechanism of action of the ribopyranoside benzimidazole GW275175X against human cytomegalovirus","volume":"48","author":"Underwood","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmcl.2025.130110_b0285","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/S0960-894X(00)00193-1","article-title":"Bicyclic nucleoside inhibitors of Varicella-Zoster Virus (VZV): the effect of a terminal halogen substitution in the side-chain","volume":"10","author":"Brancale","year":"2000","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2025.130110_b0290","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1021\/jm301778x","article-title":"Novel antiviral activity of l-dideoxy bicyclic nucleoside analogues versus vaccinia and measles viruses in vitro","volume":"56","author":"McGuigan","year":"2013","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2025.130110_b0295","first-page":"734","article-title":"New progress in medicinal chemistry of anti-poxvirus drugs research","volume":"55","author":"Zhang","year":"2020","journal-title":"Acta Pharm Sin"},{"key":"10.1016\/j.bmcl.2025.130110_b0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.cclet.2023.108349","article-title":"Medicinal chemistry strategies in the discovery and optimization of HBV core protein allosteric modulators (2018\u20132022 update)","volume":"34","author":"Shao","year":"2023","journal-title":"Chin Chem Lett"},{"key":"10.1016\/j.bmcl.2025.130110_b0305","article-title":"From design to biological mechanism evaluation of phenylalanine-bearing HIV-1 capsid inhibitors targeting a vital assembly interface","volume":"34","author":"Xu","year":"2023","journal-title":"Chin Chem Lett"},{"key":"10.1016\/j.bmcl.2025.130110_b0310","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1016\/j.drudis.2020.07.017","article-title":"Fsp3: a new parameter for drug-likeness","volume":"25","author":"Wei","year":"2020","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.bmcl.2025.130110_b0315","first-page":"285","article-title":"Recent advances in the molecular design and applications of proteolysis targeting chimera-based multi-specific antiviral modality","volume":"2","author":"Zhou","year":"2023","journal-title":"Acta Mater Med"}],"container-title":["Bioorganic &amp; Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X25000198?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X25000198?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T16:40:29Z","timestamp":1778517629000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X25000198"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":63,"alternative-id":["S0960894X25000198"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2025.130110","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nucleoside antiviral agents with atypical structures and new targets","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2025.130110","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"130110"}}